Industry News

Participate at ASH in San Diego - Booth # 815

December 2023

Theradex Oncology has confirmed its attendance at the upcoming American Society of Hematology (ASH) annual meeting in San Diego from December 9 -12, 2023. Dr. Barry Anderson and his team are ready to engage in conversations regarding the ways in which Theradex Oncology can offer assistance in drug development and... read more »

Attending AACR April 2024 – Booth # 3147

April 2024

Theradex Oncology is excited to announce our attendance at the upcoming American Association for Cancer Research (AACR) meeting in San Diego from April 5 -10, 2024. Our booth number is 3147. We invite attendees to meet with our team, including Dr. Barry Anderson, Dr. Joachim Gullbo, Judy DeChamplain, and Meg... read more »

Attending ASCO June 2024 – Booth # 33081

June 2024

Theradex Oncology will attend the upcoming American Society for Clinical Oncology (ASCO) , meeting which will take place in Chicago from May 31- June 4, 2024. Attendees can meet with Dr. Barry Anderson, Dr. Joachim Gullbo, Dr. Jack Welch, Judy DeChamplain, Meg Valnoski, and their team to explore how Theradex... read more »

Attending ESMO September 2024 congress in Barcelona

September 2024

Theradex will attend European Society for Medical Oncology (ESMO) congress in Barcelona, Spain, 13 - 17 Sep 2024. Dr Jack Welch and Hans Rosén will be available to discuss how Theradex Oncology can work with you to support your drug development and clinical trials. Please email to schedule an appointment... read more »

Theradex Oncology Awarded NCI Contract for Clinical Trial Monitoring Services

March 2023

Theradex Oncology was awarded the NCI contract and will continue to operate the Clinical Trial Monitoring Service (CTMS). Theradex has been an integral part of clinical trial management for the Early Phase Clinical Trial Network (ETCTN). Theradex Oncology continues to collaborate on early phase and randomized trials to support continued... read more »